2014 TOWARDS AN HIV CURE SYMPOSIUM, 19 & 20 JULY 2014
Under the auspices of the International AIDS Society, an international working group of researchers developed a Global Scientific Strategy: Towards an HIV Cure, which was launched in July 2012 in Washington, DC. Following a first successful workshop in Vienna at AIDS 2010, the IAS and the Towards an HIV Cure Advisory Board convened two symposia in line with the scientific priorities outlined in the Global Scientific Strategy. The symposia, organized in conjunction with the AIDS 2012 and IAS 2013 conferences, provided a platform to present state-of-the-art basic science and clinical research on the HIV cure research priority areas defined in the strategy.
Following the success of the symposia, the IAS and the Towards an HIV Cure Advisory Board will convene another 2-day symposium immediately prior to the 20th International AIDS Conference in Melbourne in July 2014.
The symposium will be co-chaired by Françoise Barré-Sinoussi, IAS President, Steven Deeks, Professor of Medicine at the University of California, San Francisco (UCSF), and Sharon Lewin, Director of the Infectious Diseases Unit, Alfred Hospital, Monash University. It is anticipated that a second symposium will give further impetus to HIV cure research, whilst also offering an important opportunity for the delegates to share ideas, debate, and network among their peers.
- Provide an opportunity for scientists who are working on HIV cure to share ideas, debate, and network among their peers
- Develop knowledge on the priorities that future research must address in order to tackle HIV persistence in patients on ART
- Accelerate research on viral reservoirs and latency as the way towards achieving a cure for HIV infection
- Promote increased investments in HIV/AIDS cure research
- Provide a platform for information-sharing between scientists, clinicians, funders, media and members of civil society.
How to attend the symposium
The symposium is open to senior, mid-career and junior scientists, clinical researchers, scientific journalists, research funding administrators and community representatives. The capacity is limited to 250 participants.
If you are interested in attending, you must apply for a registration online. Registration will be open from 1 December - 10 April. All registration applications will be reviewed after this date and notifications will be sent between 23 – 30 April 2014, after the abstracts are selected.
If you would like to submit an abstract to present at the symposium, you must use the AIDS 2014 abstract submission system, and select the option for your abstract to be considered for the Towards an HIV Cure Symposium. Abstract submission will be open from 1 December – 6 February.
All relevant abstracts in basic science, clinical studies and social sciences submitted to AIDS 2014 can be considered for oral or poster presentation at the symposium. Please refer to the abstract submission guidelines before submitting an abstract.
If you would like to apply for a scholarship to attend the symposium, you must use the AIDS 2014 scholarship application system, and indicate in Q.10 that you would be interested in attending the Towards an HIV Cure Symposium. Scholarship application will be open from 5 December – 13 February.
Please click here for more detailed information on the background and objectives of this initiative and for any additional information please contact .
The Symposium Programme Committee
- Jintanat Ananworanich, The Thai Red Cross AIDS Research Centre, Thailand
- Brigitte Autran, La Pitié-Salpétrière Hospital, France
- Françoise Barré-Sinoussi, Inserm and Institut Pasteur, France
- Steven Deeks, University of California, San Francisco (UCSF), USA
- David Evans, Project Inform, USA
- Romas Geleziunas, Gilead Sciences Inc., USA
- Jennifer Hoy, The Alfred Hospital and Monash University, Australia
- Keith Jerome, Fred Hutchinson Cancer Research Center (FHCRC), USA
- Daniel Kuritzkes, Brigham & Women’s Hospital, Harvard Medical School, USA
- Sharon Lewin, The Alfred Hospital, Monash University and Burnet Institute, Australia
- Javier Martinez-Picado, irsiCaixa Foundation, Spain
- John Mellors, University of Pittsburgh, USA
- Thumbi Ndung’u, University of KwaZulu-Natal, South Africa
- Yiming Shao, Chinese Center for Disease Control and Prevention, China